Elite Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Elite Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Elite Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Elite Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Elite Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US10213388B2 | Grant | Abuse resistant oral dosage forms | A61K31/485; A61K9/2027; A61K9/2095; A61K9/28; A61K9/2846; A61K9/2866; A61K9/2873; A61K9/2893 | February 26, 2019 |
| ES2625092T3 | Grant | Formas de dosificación orales resistentes a la adicción y método de uso de las mismas | A61K31/485; A61K9/1676; A61K9/4808; A61K9/5026; A61P25/36; A61K9/5078; A61P25/00 | July 18, 2017 |
| EP3175846A1 | Application | Missbrauchssichere orale darreichungsformen und verfahren zur verwendung davon | A61P25/00; A61K9/4808; A61K9/5026; A61K9/5078; A61P25/36; A61K31/485; A61K9/1676 | June 07, 2017 |
| EP1615623B1 | Grant | Orale sicherheitsdosierformen und anwendungsverfahren dafür | A61P25/36; A61K9/1676; A61K9/5078; A61K9/4808; A61K31/485; A61K9/5026; A61P25/00 | March 22, 2017 |
| US20150250732A1 | Application | Abuse resistant oral dosage forms | A61K31/485; A61K9/2027; A61K9/2095; A61K9/28; A61K9/2846; A61K9/2866; A61K9/2873; A61K9/2893 | September 10, 2015 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer